Lunnon Metals Limited (ASX:LM8) December 2024 Quarterly Report
Lunnon Metals Limited reports advancements in gold exploration with a cash balance of $19.5 million as of December 31, 2024.
Category: Healthcare
IDT Australia Limited (ASX:IDT) Secures $20 Million Loan Facility
IDT Australia (ASX:IDT) secures a $20 million loan facility to drive growth and enhance its sales pipeline.
Delta Lithium Limited (ASX:DLI) Announces Mt Ida Exploration Update
Delta Lithium has reported promising exploration results at its Mt Ida Gold Project, highlighting significant resource growth potential and development plans.
Adisyn Ltd (ASX:AI1) Completes $10 Million Placement
Adisyn Ltd successfully completes a $10 million oversubscribed placement to advance graphene semiconductor technologies.
Respiri Limited (ASX:RSH) Reports Record Patient Enrolment and Revenue Growth
Respiri Limited (ASX:RSH) achieved record patient enrolment and revenue growth, bolstered by the acquisition of Orb Health.
4DMedical Limited (ASX:4DX) Signs Commercial Agreement with Qscan
4DMedical Limited (ASX:4DX) has entered a commercial agreement with Qscan, expanding its respiratory imaging solutions in Australia.
Poseidon Nickel Limited (ASX:POS) Reports Quarterly Highlights
Poseidon Nickel Limited (ASX:POS) reports on its proposed merger with Horizon Minerals and positive exploration outcomes.
Paradigm Biopharmaceuticals Ltd (ASX:PAR) Secures $6.3 Million R&D Tax Incentive
Paradigm Biopharmaceuticals receives $6.3 million R&D Tax Incentive, enhancing its Phase 3 osteoarthritis clinical trial cash reserves.
SomnoMed Limited (ASX:SOM) FY25 Guidance Update and Q2 Report
SomnoMed Limited reported a 19.8% increase in Q2 revenue, updated FY25 guidance, and welcomed a new Director amidst ongoing product development efforts.
SomnoMed Limited (ASX:SOM) Reports Strong Quarterly Cash Flow
SomnoMed Limited (ASX:SOM) reports a positive cash flow of $1.525 million for the current quarter, showcasing strong operational performance.